2013
Survival and Prognostic of Stage IV Bladder Cancer in Rajavithi Hospital
31.56.015 [Abstract] | [PDF]
Correlation of Mitotic Index and Ki-67 And Their Impacts on Survival of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) at Ramathibodi Hospital
31.56.014 [Abstract] | [PDF]
Prognostic Factors For survival in Soft Tissue Sarcoma: Rajavithi Hospital Experience
31.56.013 [Abstract] | [PDF]
Prevalence of Retinoblastoma Protein in Negative Human Papilloma Virus in Non-nasopharyngeal Head and Neck Squamous Cell Carcinoma in Patients at The King Chulalongkorn Memorial Hospital
31.56.012 [Abstract] | [PDF]
Adherence to Adjuvant Chemotherapy Among Early Stage Breast Cancer Patients in Single Referral Medical Center
31.56.011 [Abstract] | [PDF]
Clinical Outcome of HER2-positive, Node-negative Breast Cancer Patients in Siriraj Hospital
31.56.010 [Abstract] | [PDF]
Incidence And Risk Factor Of Venous Thromboembolism In Northern THAI Cancer Receiving Chemotherapy Patients
31.56.009 [Abstract] | [PDF]
Androgen Receptor Expression in Triple Negative Breast Cancer in Ramathibodi Hospital
31.56.008 [Abstract] | [PDF]
Preoperative Versus Postoperative Chemotherapy in Rectal Cancer: Ramathibodi Experience
31.56.007 [Abstract] | [PDF]
การศึกษาผลการรักษาและค่ารักษาพยาบาลในผู้ป่วยโรคมะเร็งลาไส้ใหญ่ระยะแพร่กระจายที่ได้รับยา Bevacizumab ร่วมกับยาเคมีบาบัด
31.56.006 [Abstract] | [PDF]
Clinical Outcome Of Stage II-IVB Nasopharyngeal Carcinoma Patients Treated With Concurrent Chemoradiation At Seriraj Hospital
31.56.005 [Abstract] | [PDF]
Four Dihydropyrimidine Dehydrogenase Genotypes (1627A>G, 967G>A, 1774C>T and IVS14+G>A) As A Predictive Factors For Toxicity In THAI Patients Treated With Single Agent 5-FU or Capecitabine In Ramathibodi Hospital
31.56.004 [Abstract] | [PDF]
The 1-Year Outcomes Following Liver Resection For Liver Metastasis Colorectal Cancer In King Chulalongkorn Memorial Hospital
31.56.003 [Abstract] | [PDF]
Prevalance of KRAS Gene Mutation in Ampullary Cancer in THAI Patients
31.56.002 [Abstract] | [PDF]
Detection Rate of SFTPB and KRT14 Expression by Immunohistochemistry Method in Squamous Cell Carcinoma of Lung and Head-Neck Cancer Tissue
31.56.001 [Abstract] | [PDF]